In vivo experiments revealed that this engineered bacterial system exhibited excellent tumor targeting and penetration effects in CDH17‐positive solid tumors, including desmoplastic stroma‐enriched pancreatic cancer. This evidence concerns the gene CDH17 and pancreatic neoplasm.